NR5A2 and cancer: miR-139-5p was found to suppress cell proliferation and invasive capability of esophageal carcinoma cells and induce cell cycle arrest in the G0/G1 phase and in the late apoptosis of cancer cells by targeting oncogenic NR5A2.